19 December 2024
19 December 2024
In 2020, Acurable’s AcuPebble became the first device to receive a CE mark for fully automated obstructive sleep apnoea diagnosis.
The initiative is set to develop probes and primers that could be integrated into LDTs designed for H5N1 identification.
The University Hospital Southampton NHS Foundation Trust sponsored the study.
Dexcom’s OTC glucose biosensor Stelo is the first product to use the GenAI platform for improved weekly insights.
BYU researchers will analyse cell-free DNA methylation to identify early signs of neurodegeneration.
In 2021, WHO recommended breath training devices such as those manufactured by POWERbreathe for individuals recovering from Covid-19.
The first-in-human trial is taking place at Na Homolce hospital in Prague, Czechia, and will treat up to 50 patients.
The system is designed to be less invasive and can be performed by any trained healthcare worker.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
